David L Chan

11PUBLICATIONS
13CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 05, 2026
Efficacy of peptide receptor radionuclide therapy in patients with oligodiscordant gastroenteropancreatic neuroendocrine tumours.

|Apr 08, 2026
Therapy-related myeloid neoplasms following peptide receptor radionuclide therapy for neuroendocrine neoplasms: case series reporting characteristics and outcomes from single-centre experience.

Wallace Chow, Ivy Wen, Claire Mok

|Apr 02, 2023
Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach.

S Gordon, D L H Chan, E J Bernard

|Nov 26, 2022
Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.

David L Chan, Aimee R Hayes, Ioannis Karfis

|Aug 03, 2021
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review.

David L Chan, Emily K Bergsland, Jennifer A Chan

|May 21, 2021
A pilot study of everolimus and radiation for neuroendocrine liver metastases.

Sten Myrehaug, David L Chan, Victor Rodriguez-Freixinos

Pageof 2

Frequent Collaborators

2 joint publications

Alice Conner

1 joint publications

K P Willowson

1 joint publications

D L Bailey

1 joint publications

Julie Hallet